adthera bio

What are the key aspects to the success of a scaling biotech business? As part of our "Scaling Innovation in Advanced Therapy Manufacturing" series, Chris Hamilton spoke with Colin Sims, CEO & Director at adthera bio to discuss the formation of adthera and the intention of creating a service business which was highly transparent, yet highly digitised with real time capability. Watch the latest episode here: https://lnkd.in/emTSzece #Innovation #Leadership #Technology #ExecutiveSearch #WhereLeadershipMatters

Thanks to the Miltenyi Biotec team for supporting a novel way of communicating challenges in the GCT arena. Here at adthera bio, we have a focus on digital solutions for the future manufacturing and development needs of the cell therapy industry. Reach out if you would like to know more about our journey. #digitalfirst #atmp #rightfirsttime

What's stopping us? What's holding the industry back in delivering ATMPs at scale to patients? The panel session entitled: Make Them Better at #AdvancedTherapiesIntegrates delved deep into this question: ➡️ Consider the phase - we're at the beginning still (think mobile phones 35 years ago!) 🤝 Collaboration - including finding common/best systems and commercial niches 💻 Digitalisation - how can it support us and where are the low hanging fruits (automation in data collection and exchange, for example) 💪 Resilience in the supply chain - and its link to visibility 📈 Risk - and how to manage and learn from other industries to manufacture at scale 👍 Standardisation - across the board, from workflows to AI Thanks to the panellists for the dynamic discussion - Rebecca Street from RoslinCT, Katy Newton from Achilles Therapeutics plc, Antoine Espinet from MFX, Edwin Stone from Cellular Origins, Kwok Pang from adthera bio and facilitator Stephen Ward, Chief Technology Officer, Cell and Gene Therapy Catapult

At adthera, we are committed to accelerating the delivery of advanced therapy medicinal products (ATMPs) with our unique and integrated approach. Our capabilities span the entire lifecycle of cell and gene therapy development, ensuring that innovative treatments reach patients with speed, efficiency, and the highest quality standards. 📊 Our Core Capabilities: Therasplore™ Development Process: Our platform-agnostic cell therapy development expertise allows us to innovate and refine therapies tailored to specific needs, ensuring robust and scalable solutions. Theramake™ GMP Excellence Manufacturing System: We provide scalable GMP manufacturing capabilities that ensure compliance and quality, leveraging state-of-the-art facilities to bring your cell therapy products to life. Theraconsult™ Advisory Consulting Platform: Our data-driven analytics optimize quality, processes, and outcomes, providing actionable insights that enhance every stage of therapy development and manufacturing. 🔬 Why Choose Adthera Bio?: Innovative Solutions: Our team combines deep scientific knowledge with cutting-edge technology to push the boundaries of cell and gene therapy. Quality and Compliance: We maintain rigorous standards to ensure every product meets regulatory requirements and delivers optimal patient outcomes. Customer-Centric Approach: We partner closely with biotechs and academic centers, offering personalized solutions that address unique challenges and goals. #cdmo #regenerativemedicine #digitalfirst #celltherapy #immunotherapy #innovation #processdevelopment #continousimprovement #gmp #clinicaltrials #atmp #advancedtherapies #personalizedmedicine #gxp #optimization #automation #bestinclass #rightfirsttime #celltherapymanufacturing #innovation #digital #partnerships #collaboration #networking #digitaltransformation #quailtycontrol #qualityassurance #GMP #simulation #manufacturing #processdevelopment

🌟 Connect with us at the AMC 26th Technical Event in Sheffield! 🌟 Toby Proctor, Head of MSAT at adthera, will be attending the AMC 26th Technical Event on Thursday, November 7, 2024 in Sheffield. This year’s theme, “Is the UK ready for the next wave of Advanced Therapies?”, promises insightful discussions on the future of advanced therapies in the UK. At adthera, we are committed to driving innovation in cell and gene therapy with a digital-first approach that accelerates process development, ensures high quality, and supports scalable solutions. If you're attending the event, connect with us to discuss how adthera can support your journey in advanced therapies. We look forward to sharing ideas, exploring partnerships, and being part of the exciting future of this field. 📩 Interested in learning more? Reach out to us at info@adthera.bio #AdvancedTherapies #CellTherapy #GeneTherapy #Biotech #adthera #Innovation #Healthcare #LifeSciences #AMCEvent #Networking #UKBiotech #AMC

#innovation #roundtable #biopharma Compass Carter Osborne

🌟 Exciting Leadership Announcement at adthera! 🌟 We are incredibly privileged to welcome Usman "Oz" Azam as the new Chairman of adthera bio! 🚀 Oz brings a wealth of experience and a visionary approach that aligns perfectly with adthera’s mission to deliver breakthrough solutions in process development and analytical development for cell and gene therapies. As Oz has emphasized, these are still some of the most significant challenges for companies looking to succeed in this field, and adthera is at the forefront of tackling them. What truly excites Oz, and us all, is adthera’s laser-focused commitment to digitalization and innovation. From supply chain advancements to quality by design, we are pioneering novel solutions that will shape the future of this sector. Oz is thrilled to partner with the entire adthera team to help drive meaningful progress for patients and the industry over the next 12 to 18 months. We are on the brink of achieving game-changing milestones that will push the boundaries of cell and gene therapy. Stay tuned for the incredible journey ahead! 💡 Follow us for updates on our innovations and milestones: 📲 www.adthera.bio 📈 Follow adthera #cdmo #regenerativemedicine #digitalfirst #celltherapy #immunotherapy #innovation #processdevelopment #continousimprovement #gmp #clinicaltrials #atmp #advancedtherapies #personalizedmedicine #gxp #optimization #automation #leadership #bestinclass #rightfirsttime #celltherapymanufacturing #innovation #digital #partnerships #collaboration #networking #digitaltransformation #quailtycontrol #qualityassurance #GMP #simulation #manufacturing #processdevelopment

🎉 Exciting Leadership News at adthera! 🎉 We are thrilled to announce that Usman "Oz" Azam has joined adthera bio as our new Chairperson! 🚀 Dr. Azam brings an incredible wealth of experience to adthera, with a proven track record across clinical medicine, big pharma, biotech, and fundraising. As the founder of multiple innovative companies and a leading figure in the cell and gene therapy space, Oz’s deep expertise and vast network will be instrumental in accelerating adthera’s mission of transforming the future of cell therapy manufacturing. As a clinical physician, a successful CEO, and a visionary leader in the biotech world, Oz’s leadership will further strengthen our digital-first approach to CDMO services, helping us deliver outstanding outcomes for our clients and the patients they serve. Stay tuned for more updates as we continue to push the boundaries of cell and gene therapy! 💡 Follow us for the latest insights and developments as we grow with Oz on board. 🔗 Visit us at: www.adthera.bio 📈 Stay connected: Follow adthera #cdmo #regenerativemedicine #digitalfirst #celltherapy #immunotherapy #innovation #processdevelopment #continousimprovement #gmp #clinicaltrials #atmp #advancedtherapies #personalizedmedicine #gxp #optimization #automation #bestinclass #rightfirsttime #celltherapymanufacturing #innovation #digital #partnerships #collaboration #networking #digitaltransformation #quailtycontrol #qualityassurance #GMP #simulation #manufacturing #leadership Colin Sims

Thank you Chris Hamilton and all at Odgers Berndtson - it was great meeting you and working together #purposeful business #innovation #digitalfirst

Announcing our headline sponsor for Advanced Therapies Integrates, Cell and Gene Therapy Catapult! The Cell and Gene Therapy Catapult is an independent innovation and technology organisation committed to the advancement of cell and gene therapies with a vision of a thriving industry delivering life changing advanced therapies to the world. Its aim is to create powerful collaborations which overcome challenges to the advancement of the sector. With over 400 experts covering all aspects of advanced therapies, it applies its unique capabilities and assets, collaborates with academia, industry and healthcare providers to develop new technology and innovation. Dr Stephen Ward, newly appointed Chief Technology Officer, told us about his view of the sector in advance of chairing ‘Make Them Better’ at #AdvancedTherapiesIntegrates on the 26th November. Joining him on the panel will be Rebecca Street, Head of Digital Operations at RoslinCT Katy Newton, Senior Vice President immunology and Process Development at Achilles Therapeutics plc Antoine Espinet, Co Founder & Chief Executive Officer at MFX Edwin Stone, Chief Executive Officer at Cellular Origins Kwok Pang, Chief Digital Officer at adthera bio Make sure you don't miss your opportunity to join us in Stevenage by booking your ticket now! https://lnkd.in/ewpqAFRp